BioCryst Pharmaceuticals, Inc. logo

BioCryst Pharmaceuticals, Inc.

NASDAQ:BCRX

Overview | Financials
Company Name BioCryst Pharmaceuticals, Inc.
Symbol BCRX
Currency USD
Price 7.67
Market Cap 1,586,815,620
Dividend Yield 0%
52-week-range 4.03 - 8.88
Industry Biotechnology
Sector Healthcare
CEO Mr. Jon P. Stonehouse
Website https://www.biocryst.com

An error occurred while fetching data.

About BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing

Related Stocks

Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc.

AUPH

8.34 USD

SpringWorks Therapeutics, Inc. logo

SpringWorks Therapeutics, Inc.

SWTX

33.09 USD

Apollo Medical Holdings, Inc. logo

Apollo Medical Holdings, Inc.

AMEH

40.82 USD

Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc.

FLGT

22.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD